![Andrey Mladentsev](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Healthcare professional.
Former VP CIS & Baltics at Stada, CEO at Promomed, CEO at NizhPharm (acquired by Stada), CEO at OBL Pharm (acquired by AFK Sistema).
Anciens postes connus de Andrey Mladentsev
| Sociétés | Poste | Fin |
|---|---|---|
| STADA ARZNEIMITTEL | Private Equity Investor | 01/03/2007 |
V12 Venture Israel MC Ltd.
 V12 Venture Israel MC Ltd. Investment ManagersFinance V12 Venture Israel invests in companies located in Israel. The firm focuses on companies operating in the fields of deep technology services. It provides financing for seed and early stage capital requirements. | Consultant / Advisor | - |
Formation de Andrey Mladentsev
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
STADA Arzneimittel AG
 STADA Arzneimittel AG Pharmaceuticals: GenericHealth Technology Manufactures generic drugs and pharmaceuticals | Health Technology |
IEDC Bled School of Management
 IEDC Bled School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
V12 Venture Israel MC Ltd.
V12 Venture Israel MC Ltd. Investment ManagersFinance V12 Venture Israel invests in companies located in Israel. The firm focuses on companies operating in the fields of deep technology services. It provides financing for seed and early stage capital requirements. | Finance |
